Acarix AS (Sweden) Performance

ACARIX Stock  SEK 0.25  0.01  3.85%   
The firm shows a Beta (market volatility) of 0.24, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Acarix AS's returns are expected to increase less than the market. However, during the bear market, the loss of holding Acarix AS is expected to be smaller as well. At this point, Acarix AS has a negative expected return of -0.14%. Please make sure to confirm Acarix AS's standard deviation, kurtosis, relative strength index, as well as the relationship between the maximum drawdown and day median price , to decide if Acarix AS performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Acarix AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors. ...more
Begin Period Cash Flow64.1 M
Total Cashflows From Investing Activities-43 K
  

Acarix AS Relative Risk vs. Return Landscape

If you would invest  28.00  in Acarix AS on October 29, 2025 and sell it today you would lose (3.00) from holding Acarix AS or give up 10.71% of portfolio value over 90 days. Acarix AS is generating negative expected returns and assumes 3.4106% volatility on return distribution over the 90 days horizon. Simply put, 30% of stocks are less volatile than Acarix, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon Acarix AS is expected to under-perform the market. In addition to that, the company is 4.57 times more volatile than its market benchmark. It trades about -0.04 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.09 per unit of volatility.

Acarix AS Target Price Odds to finish over Current Price

The tendency of Acarix Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.25 90 days 0.25 
about 92.15
Based on a normal probability distribution, the odds of Acarix AS to move above the current price in 90 days from now is about 92.15 (This Acarix AS probability density function shows the probability of Acarix Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon Acarix AS has a beta of 0.24. This suggests as returns on the market go up, Acarix AS average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Acarix AS will be expected to be much smaller as well. Additionally Acarix AS has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Acarix AS Price Density   
       Price  

Predictive Modules for Acarix AS

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Acarix AS. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.010.253.63
Details
Intrinsic
Valuation
LowRealHigh
0.010.233.61
Details
Naive
Forecast
LowNextHigh
0.010.263.64
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.240.270.29
Details

Acarix AS Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Acarix AS is not an exception. The market had few large corrections towards the Acarix AS's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Acarix AS, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Acarix AS within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.2
β
Beta against Dow Jones0.24
σ
Overall volatility
0.02
Ir
Information ratio -0.08

Acarix AS Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Acarix AS for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Acarix AS can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Acarix AS generated a negative expected return over the last 90 days
Acarix AS has some characteristics of a very speculative penny stock
Acarix AS has high historical volatility and very poor performance
Acarix AS has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 3.76 M. Net Loss for the year was (51.73 M) with profit before overhead, payroll, taxes, and interest of 2.82 M.
Acarix AS has accumulated about 15.86 M in cash with (48.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.24, which can makes it an attractive takeover target, given it will continue generating positive cash flow.

Acarix AS Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Acarix Stock often depends not only on the future outlook of the current and potential Acarix AS's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Acarix AS's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding150.3 M
Cash And Short Term Investments15.8 M

Acarix AS Fundamentals Growth

Acarix Stock prices reflect investors' perceptions of the future prospects and financial health of Acarix AS, and Acarix AS fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Acarix Stock performance.

About Acarix AS Performance

By analyzing Acarix AS's fundamental ratios, stakeholders can gain valuable insights into Acarix AS's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Acarix AS has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Acarix AS has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Acarix AB , a medical technology company, develops and commercializes diagnostic tests for cardiovascular diseases primarily in Europe, China, and the United States. Acarix AB was founded in 2004 and is based in Malm, Sweden. Acarix AB operates under Medical Devices classification in Sweden and is traded on Stockholm Stock Exchange. It employs 11 people.

Things to note about Acarix AS performance evaluation

Checking the ongoing alerts about Acarix AS for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Acarix AS help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Acarix AS generated a negative expected return over the last 90 days
Acarix AS has some characteristics of a very speculative penny stock
Acarix AS has high historical volatility and very poor performance
Acarix AS has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 3.76 M. Net Loss for the year was (51.73 M) with profit before overhead, payroll, taxes, and interest of 2.82 M.
Acarix AS has accumulated about 15.86 M in cash with (48.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.24, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Evaluating Acarix AS's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Acarix AS's stock performance include:
  • Analyzing Acarix AS's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Acarix AS's stock is overvalued or undervalued compared to its peers.
  • Examining Acarix AS's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Acarix AS's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Acarix AS's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Acarix AS's stock. These opinions can provide insight into Acarix AS's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Acarix AS's stock performance is not an exact science, and many factors can impact Acarix AS's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Acarix Stock analysis

When running Acarix AS's price analysis, check to measure Acarix AS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acarix AS is operating at the current time. Most of Acarix AS's value examination focuses on studying past and present price action to predict the probability of Acarix AS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acarix AS's price. Additionally, you may evaluate how the addition of Acarix AS to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Commodity Directory
Find actively traded commodities issued by global exchanges
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals